scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...879542P |
P356 | DOI | 10.1371/JOURNAL.PONE.0079542 |
P932 | PMC publication ID | 3832612 |
P698 | PubMed publication ID | 24260246 |
P5875 | ResearchGate publication ID | 258826077 |
P50 | author | Brian W. Simons | Q55381217 |
Javid A Dar | Q57046456 | ||
Laura E Pascal | Q57144929 | ||
Khalid Z. Masoodi | Q48235634 | ||
P2093 | author name string | Dan Wang | |
Xinhui Wang | |||
Zhou Wang | |||
Anil V Parwani | |||
Yujuan Wang | |||
Luyuan Li | |||
Junkui Ai | |||
Lora H Rigatti | |||
Kurtis Eisermann | |||
Benjamin J Davies | |||
Hei M Ma | |||
Katherine J O'Malley | |||
Michael M Ittman | |||
P2860 | cites work | Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts | Q73436686 |
Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues | Q74093343 | ||
Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate | Q77359737 | ||
Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model | Q78469525 | ||
Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice | Q79370200 | ||
ADAMTS1, a putative anti-angiogenic factor, is decreased in human prostate cancer | Q84065037 | ||
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis | Q24681977 | ||
Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
PTEN: one gene, many syndromes | Q28203387 | ||
Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate | Q28568984 | ||
Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer | Q28587720 | ||
U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia | Q28590029 | ||
Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experience | Q30483391 | ||
Androgen regulation of spermidine synthase expression in the rat prostate | Q31040745 | ||
The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia | Q33493120 | ||
U19/Eaf2 binds to and stabilizes von hippel-lindau protein | Q33590977 | ||
PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification | Q33600700 | ||
Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53 | Q33604141 | ||
CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker | Q33609625 | ||
The effects of aging on the molecular and cellular composition of the prostate microenvironment | Q33687098 | ||
TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse | Q33741877 | ||
VHL and PTEN loss coordinate to promote mouse liver vascular lesions | Q33862155 | ||
Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion | Q33892041 | ||
The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression | Q34045475 | ||
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer | Q34272599 | ||
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells | Q34340236 | ||
Reactive stroma in prostate cancer progression | Q34429976 | ||
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens | Q34756267 | ||
EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate | Q35161330 | ||
Tumor progression: the effects of thrombospondin-1 and -2. | Q35749722 | ||
Androgen deprivation induces rapid involution and recovery of human prostate vasculature | Q35760385 | ||
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development | Q36017017 | ||
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression | Q36067596 | ||
Genes regulated by androgen in the rat ventral prostate | Q36715055 | ||
Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate. | Q37373807 | ||
Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. | Q38362968 | ||
Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia | Q38457725 | ||
Differential Inductive Signaling of CD90 Prostate Cancer-Associated Fibroblasts Compared to Normal Tissue Stromal Mesenchyme Cells. | Q39556027 | ||
Crucial role of the sarcoplasmic reticulum in the developmental regulation of Ca2+ transients and contraction in cardiomyocytes derived from embryonic stem cells. | Q40358000 | ||
Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines | Q40597735 | ||
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium | Q40923257 | ||
Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation | Q44320388 | ||
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification | Q44966383 | ||
A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization | Q45189219 | ||
The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone. | Q46033903 | ||
Independent association of angiogenesis index with outcome in prostate cancer | Q46071411 | ||
Expression of murine ELL‐associated factor 2 (Eaf2) is developmentally regulated | Q46383343 | ||
A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections | Q46493041 | ||
Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of progression? | Q47689089 | ||
A set of novel tadpole specific genes expressed only in the epidermis are down-regulated by thyroid hormone during Xenopus laevis metamorphosis | Q48053838 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | intraepithelial neoplasia | Q6058399 |
prostatic intraepithelial neoplasia | Q54911767 | ||
P304 | page(s) | e79542 | |
P577 | publication date | 2013-11-18 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice | |
P478 | volume | 8 |
Q47657085 | Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice. |
Q61455990 | Concurrent EAF2 and ELL2 loss phenocopies individual EAF2 or ELL2 loss in prostate cancer cells and murine prostate |
Q92961694 | Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice |
Q47701028 | Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia |
Q52666493 | EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. |
Q90643584 | EAF2 loss induces prostatic intraepithelial neoplasia from luminal epithelial cells in mice |
Q36661580 | EAF2 mediates germinal centre B-cell apoptosis to suppress excessive immune responses and prevent autoimmunity. |
Q37746393 | EAF2 regulates DNA repair through Ku70/Ku80 in the prostate. |
Q53421985 | Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences. |
Q90227095 | Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells |
Q37301786 | Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells |
Search more.